Position in EVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$50,094
+$747 QoQ
Shares Held
17,891
-9.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 34 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026XTX Topco Ltd holds $78,752,334 across 60 Drug Manufacturers - Specialty & Generic names. EVO ranks #47 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
193,067 | $13,873,794 | |
| 2 | VTRS |
Viatris Inc
|
630,996 | $10,020,216 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
13,055 | $7,073,590 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
204,521 | $5,033,261 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
27,124 | $4,571,478 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
117,664 | $4,079,410 | |
| 7 | PRGO |
PERRIGO Co plc
|
275,509 | $2,862,538 | |
| 8 | ALKS |
Alkermes plc.
|
50,788 | $2,661,291 |
All Filings in EVO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,094 | 17,891 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $49,347 | 19,739 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $56,884 | 18,469 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $53,578 | 14,760 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $65,507 | 15,597 | Shares | Defined | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||